For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...

Research published in The Lancet HIV earlier this year, experts estimated that, if purchased at scale, the cost of generic lenacapavir could range from USD 35 to USD 46 per person-year. Falling to USD ...

Florida will get $3 million as part of a nationwide settlement over allegations a drug manufacturer gave kickbacks to doctors ...

Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...

Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

In Zambia, we met people who are HIV positive, couldn't get drugs to suppress the virus after U.S. aid cuts and were seeing ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. Hello there from STAT reporter Andrew Joseph, filling in for Mr.

Gilead Sciences, the largest maker of HIV medicines, is seeking to boost prices significantly for several treatments that are widely distributed by state AIDS Drug Assistance Programs. And the move is ...

The number of HIV/Aids-related deaths in Kenya has dropped by more than half over the past decade, driven by strengthened local interventions and lifesaving antiretroviral (ARV) treatments, which are ...